{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:33:06Z","timestamp":1772253186989,"version":"3.50.1"},"reference-count":13,"publisher":"Sociedade Brasileira de Cardiologia","issue":"5","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Bras. Cardiol."],"DOI":"10.36660\/abc.20250233","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:38:31Z","timestamp":1750174711000},"source":"Crossref","is-referenced-by-count":0,"title":["Taquicardia Ventricular N\u00e3o Sustentada e Cardiomiopatia Hipertr\u00f3fica: Quando Consider\u00e1-la como Fator de Risco para Morte S\u00fabita e Mortalidade Total?"],"prefix":"10.36660","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8803-8115","authenticated-orcid":false,"given":"Lucas Simonetto","family":"Faganello","sequence":"first","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-5349","authenticated-orcid":false,"given":"Mauricio","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review","volume":"79","author":"Maron BJ","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy: An Independent Marker of Sudden Death Risk in Young Patients","volume":"42","author":"Monserrat L","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical Trends in Reported Survival Rates in Patients with Hypertrophic Cardiomyopathy","volume":"92","author":"Elliott PM","year":"2006","journal-title":"Heart"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","article-title":"Prognostic Significance of 24 Hour Ambulatory Electrocardiographic Monitoring in Patients with Hypertrophic Cardiomyopathy: A Prospective Study","volume":"48","author":"Maron BJ","year":"1981","journal-title":"Am J Cardiol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and Prognostic Significance of Arrhythmias on Ambulatory Holter Electrocardiogram in Hypertrophic Cardiomyopathy","volume":"45","author":"Adabag AS","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004604","article-title":"Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients with Hypertrophic Cardiomyopathy","volume":"10","author":"Wang W","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10741-023-10355-w","article-title":"Current Perspectives of Sudden Cardiac Death Management in Hypertrophic Cardiomyopathy","volume":"29","author":"Pu L","year":"2024","journal-title":"Heart Fail Rev"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen SR","year":"2024","journal-title":"Circulation"},{"issue":"37","key":"ref9","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the Management of Cardiomyopathies","volume":"44","author":"Arbelo E","year":"2023","journal-title":"Eur Heart J"},{"issue":"127","key":"ref10","article-title":"Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024","volume":"121","author":"Fernandes F","year":"2024","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20240399i","article-title":"Prognostic Value of Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy in a Brazilian Cohort: Comparison with World Literature","volume":"122","author":"Silva DA","year":"2025","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5334\/gh.1380","article-title":"Validation of ACC\/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study","volume":"19","author":"Antunes MO","year":"2024","journal-title":"Glob Heart"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2024.11.007","article-title":"Low Agreement among Guidelines for Primary Prevention Implantable Cardioverter-Defibrillator Recommendations in Hypertrophic Cardiomyopathy","volume":"236","author":"Scolari FL","year":"2025","journal-title":"Am J Cardiol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":["Non-sustained Ventricular Tachycardia and Hypertrophic Cardiomyopathy: When to Consider it as a Risk Factor for Sudden Death and Total Mortality?"],"link":[{"URL":"https:\/\/abccardiol.org\/wp-content\/uploads\/articles_xml\/0066-782X-abc-122-05-e20250233\/0066-782X-abc-122-05-e20250233.x95083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:38:34Z","timestamp":1750174714000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/short-editorial\/taquicardia-ventricular-nao-sustentada-e-cardiomiopatia-hipertrofica-quando-considera-la-como-fator-de-risco-para-morte-subita-e-mortalidade-total\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"alternative-id":["S0066-782X2025000500203"],"URL":"https:\/\/doi.org\/10.36660\/abc.20250233","relation":{"is-translation-of":[{"id-type":"doi","id":"10.36660\/abc.20250233i","asserted-by":"subject"},{"id-type":"doi","id":"10.36660\/abc.20250233i","asserted-by":"object"}]},"ISSN":["1678-4170","0066-782X"],"issn-type":[{"value":"1678-4170","type":"electronic"},{"value":"0066-782X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e20250233"}}